Scientists have achieved a significant breakthrough in Parkinson’s research, developing a novel technique that can detect tiny brain clusters believed to trigger the debilitating disease.
A hallmark of Parkinson’s is the presence of abnormal protein clumps, known as Lewy bodies, in the brain. However, some researchers postulate that these larger formations originate from much smaller, toxic groupings called alpha-synuclein oligomers – clusters of the α-synuclein protein.